Principal business is the discovery, development, manufacture and sale of a broad and diversified line of health care products. Company has four segments: Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Vascular Products.


Updates from The Motley Fool

Latest updates on Abbott Laboratories from Fool.com.


Stock Performance

ABT vs. S&P 500 | 2 Year Performance
View Interactive ABT Charts
Sponsored by

Key Data Points

Primary metrics and data points about Abbott Laboratories.
Current Price: $42.98
Prev Close: $42.84
Open: $42.72
Bid: $42.96
Ask: $44.00
Day's Range: $42.09 - $43.28
52wk Range: $36.00 - $46.63
Volume: 18,663,420
Avg Vol 10,032,880
Market Cap: $64.11B
P/E (ttm): 32.95
EPS (ttm): $1.30
Div & Yield: $1.04 (2.4%)

Company Rating

What our community thinks about Abbott Laboratories.
CAPS Rating 5 out of 5
 
2485 Outperform
95 Underperform
CAPS All Stars
 
597 Outperform
12 Underperform

How do you think Abbott Laboratories will perform against the market?



You pick for Abbott Laboratories is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS


CEO Rating

The single most important factor in a company's success is the team that's leading the company.

Miles D. White, CEO

81% Approve

Based on 473 Ratings

Powered by Glassdoor

Business Summary

Industry, sector and description for Abbott Laboratories.

Principal business is the discovery, development, manufacture and sale of a broad and diversified line of health care products. Company has four segments: Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Vascular Products.

  • Exchange: NYSE
  • Sector: Healthcare
  • Industry: Drug Makers